Clinical Trials Logo

Clinical Trial Summary

Hypothalamic amenorrhea (HA) occurs during reproductive years and results in stopped menstrual cycles and infertility which can be prolonged from months to years and is characterized by varying combinations of psychosocial stress, anxiety, high levels of physical activity, and/or weight loss. Data from our group indicates that one-third of women with HA (mean age: 27 yrs) have preclinical cardiovascular disease (CVD) measured noninvasively as vascular dysfunction and vascular inflammation. This study will use HA as a marker of fertility status for cardiovascular health and perform dense-phenotyping using remote patient monitoring (FitBit) and patient reported outcomes (questionnaires) to determine which HA phenotypes are related to preclinical CVD and inflammation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05629377
Study type Observational
Source Mayo Clinic
Contact Chrisandra Shufelt, MD
Phone 904-953-2160
Email Shufelt.Chrisandra@mayo.edu
Status Recruiting
Phase
Start date January 17, 2023
Completion date May 2026

See also
  Status Clinical Trial Phase
Recruiting NCT02984696 - Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea N/A
Recruiting NCT01601171 - Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Completed NCT00556036 - Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
Terminated NCT01165619 - Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders N/A
Recruiting NCT03841981 - Body Fat as Determinant of Female Gonadal Dysfunction
Completed NCT03018366 - Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women Phase 2
Recruiting NCT05633966 - Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders Phase 1
Terminated NCT00889512 - The Luveris In Vitro Fertilization Trial Phase 4